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BACKGROUND: Type 2 Diabetes Mellitus is a very well known metabolic disorder that has reached 
epidemic proportions worldwide. Evidence suggests that oxidative stress increases in Diabetes Mellitus 
because of the excessive production of reactive oxygen species and an impaired antioxidant defence 
mechanism. This study estimated, compared and correlated the serum and salivary Superoxide dismutase 
levels in healthy subjects and subjects with Type 2 Diabetes Mellitus having oral manifestations. 
MATERIALS AND METHODS: In this study, serum and salivary Superoxide dismutase levels were 
estimated in 45 healthy subjects and 45 patients with Type 2 Diabetes Mellitus with oral manifestations. 
RESULTS: The mean serum and salivary Superoxide dismutase levels were significantly decreased in 
subjects with Type 2 Diabetes Mellitus with oral manifestations compared to the healthy subjects. 
Positive correlation in both healthy and diabetics was observed between serum and salivary samples. 
CONCLUSION: This study highlights that the abnormally high levels of oxidative stress in diabetics 
coupled with simultaneous decline in antioxidant defence mechanism results in complications in 
Diabetes mellitus. Thus exploring saliva for antioxidant markers that accurately reflect the redox status 
of the body is worthwhile.  
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INTRODUCTION  
 
Diabetes mellitus (DM) in all its heterogeneity has 
taken the centre stage as one of the ultimate 
medical challenges (1). Type 2 DM was first 
described as a component of metabolic syndrome 
in 1988. Type 2 DM (formerly known as non-
insulin dependent DM) is the most common form 
of DM characterized by hyperglycemia, insulin 
resistance and relative insulin deficiency (2). 
Antioxidants can be defined as substances whose 
presence in relatively high concentration 
significantly inhibits the rate of oxidation of lipids, 
proteins, carbohydrates and DNA. Antioxidants 
such as superoxide dismutase (SOD) act as potent 
electron donors; they donate hydrogen atoms to 
pair up with unpaired electrons on free radicals. 
Thus, they convert reactive free radicals into 
inactive substances (3). 
Antioxidants are classified according to their 
mode of action as preventive and scavenging 
antioxidants. Preventive antioxidants suppress the 
formation of free radicals (e.g. enzymes 
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such as superoxide dismutase (SOD), catalase 
(CAT), glutathione reductase (GR), glutathione 
peroxidase (GPx) and metal ion sequestrators such 
as albumin, lactoferrin, transferring and 
haptoglobin). Scavenging (chain-breaking) 
antioxidants scavenge radicals to inhibit the chain 
initiation and break chain propagation.  They 
include vitamin C, vitamin A, vitamin E and uric 
acid (4).
 
SOD is a key antioxidant enzyme that 
dismutates superoxide anion (O2-) to continuously 
form H2O2 and O2 (4). The determination of the 
oxidative stress and antioxidants sometimes 
require invasive techniques such as taking blood 
samples. Exploring saliva for oxidative stress and 
antioxidant markers that accurately reflect the 
redox status of the body has great clinical interest 
(3).
 
This study was undertaken to estimate the 
levels of Superoxide dismutase (SOD) in the 
serum and saliva of patients with type 2 diabetes 
mellitus with oral manifestations and healthy 
controls. Further, correlation was also done 
between the salivary and serum levels of 
Superoxide dismutase in the study groups.   
 
MATERIALS AND METHODS 
 
This study was a case control study conducted on 
subjects reporting to Department of Oral Medicine 
and Radiology at a Dental Science Institute in 
South India during 2012-2014. Sample size was 
determined based on the pilot study performed on 
10 individuals in each group; 0.44 was the 
expected mean difference between the two groups. 
Sample size estimation was done by finding out 
the mean difference between two groups and 
pooled Standard Deviation and applying it to a 
standard formula to find out the sample size. This 
resulted in the sample size of 44.42. 
As the sample size denotes, it is the minimum 
sample to estimate and to calculate for the 
statistical analysis. We rounded 44.42 into 45 so 
as to reduce the errors. Sample size of 90 subjects 
were divided into 2 equal groups of 45 patients 
each: 
Control Group (Group I): 45 healthy subjects 
without any oral and systemic diseases. 
Study Group (Group II): 45 subjects diagnosed 
clinically with type 2 diabetes mellitus with 
laboratory investigations for confirmation and 
with oral manifestations. The study group 
included subjects who were diagnosed with type 2 
diabetes mellitus for more than 5 years. 
Convenient sampling technique was used to 
recruit individuals under the control and the study 
groups. For both the control and the study groups, 
strict inclusion criteria were followed. Healthy 
subjects in the age group of 30 - 60 years and 
without any history of oral and systemic diseases 
were taken as controls.  
Laboratory investigations were carried out to 
rule out undiagnosed type 2 diabetes mellitus. 
Subjects included in the Group I were not on any 
medications and did not have adverse oral habits 
like smoking, tobacco chewing and alcohol 
consumption. 
The study group consisted of subjects in the 
age group of 30 – 60 years, clinically diagnosed 
with type 2 diabetes mellitus and confirmed with 
laboratory investigations. It included patients who 
were diagnosed with type 2 diabetes mellitus for 
more than 5 years and under oral hypoglycemic 
drugs. Subjects with oral manifestations of 
diabetes mellitus like burning mouth syndrome, 
candidiasis, dental caries, gingivitis, glossodynia, 
lichen planus, neurosensory dysesthesias, 
periodontitis, salivary dysfunction, taste 
dysfunction and xerostomia were included in the 
study group.  
Subjects with history of any systemic 
diseases (other than type 2 diabetes mellitus) were 
excluded from the study. Pregnant and lactating 
women were also excluded from the study. 
Patients diagnosed with any malignancies were 
not included in the study. Subjects who were on 
any medications other than oral hypoglycemic 
drugs were excluded. Subjects with any other oral 
mucosal lesions other than those stated in 
inclusion criteria were not considered for the 
study. Those patients who have adverse oral habits 
like smoking, tobacco chewing and alcohol 
consumption were omitted from the study. Each 
patient was thoroughly examined both intra orally 
and extra orally under artificial light.  
 




Informed consent was obtained from the patients 
included in the study. Ethical clearance was 
obtained from A. B. Shetty Memorial Institute of 
Dental Sciences Central Ethical Committee (A 
Constituent Unit of Nitte University) Deralakatte, 




Mangalore – 575018.   Detailed case history was 





All salivary samples were collected from patients 
2 hours after food using spit technique. Patients 
were asked to sit in the dental chair with head 
tilted forward and instructed not to speak or 
swallow any saliva. Then, they were instructed to 
spit in a sterile graduated container every minute 
for 5-8 minutes. Salivary sample represents whole 
mouth fluid (Major and minor salivary glands and 
gingival crevicular fluid).The collected sample 
was centrifuged at 3000rpm for 10 minutes, and 






5 millilitre of venous blood was collected from the 
antecubital vein with syringe and placed in vials. 
Serum was then extracted and stored at 
temperature of -20
0
C in glass vials. The blood was 
collected into a grey coloured tube containing 
20µl fluoride oxalate to prevent clotting of blood 
and degradation of glucose.  
Estimation of Random Blood sugar levels 
was done by GOD-POD (Glucose oxidase - 
Peroxidase Method) methodology.  
 
GOD-POD (GLUCOSE OXIDASE – 




Glucose R1                                                     
4X100 ml/4X250 ml/4X500 ml/8X250 ml 
 
Phosphate buffer, (pH 7.40) :                                                   
100 mmol/l 
Phenol :                                                                                        
10 mmol/l 
Glucose R2  
4X100 ml/4X250 ml/4X500 ml/8X250 ml 
Glucose oxidase :                                                                     
> or = 10,000 U/L 
Peroxidase :                                                                             
> or = 600 U/L 
4-aminoantipyrine :                                                                  
270 mmol/l 
Glucose standard                                          
1X5ml/2X5ml/2X5ml 
Glucose standard concentration :                                 
100 mg/dl 
 
Preparation and stability of working reagent 
 
The reagent 2 (R2) was dissolved with the volume 
of reagent 1 (R1).  
 
 
            Blank       Standard       Sample 
Working reagent           1000µl         1000µl        1000µl 
Standard               -           10µl             - 
Sample               -              -            10µl 
 
Reagents were mixed and incubated for 10 
minutes at 37
0
C. The absorbance of standard and 
sample were measured against reagent blank. 
 
Calculation for end point test 
 
GLUCOSE CONC. mg/dL = Absorbance of 
sample / Absorbance of standard X 100 (5). 
  
ESTIMATION OF SOD (SUPEROXIDE 
DISMUTASE) BY NBT 
(NITROBLUETETRAZOLIUM METHOD) 
(BEAUCHAMP AND FRIDOVICH 
METHOD)  
Blood was collected in a purple coloured EDTA 
[Ethylene diaminetetraacetic acid (the potassium 
salt or K2EDTA)] tube.  
Procedure- 0.1ml of salivary filtrate /blood 
for each sample was analyzed and a corresponding 
control was maintained. The beakers were named 
as:- 
TEST [2.5 ml of methionine, 0.3 ml 
Riboflavin, 0.1 ml NBT and 0.1 ml of salivary 
filtrate]. 
STANDARD [2.5ml methionine, 0.3 ml 
Riboflavin, 0.1 ml NBT, 0.1 ml phosphate buffer 
0.05 M (pH 7.8)] and 
CONTROL [2.5 ml Methionine, 0.3 ml 
riboflavin, 0.1 ml phosphate buffer 0.05 M (pH 
7.8), 0.1 ml salivary filtrate]. They were subjected 
to illumination for 10 minutes in an illumination 
chamber lined with aluminum foil and fitted with 
a 15W fluorescent lamp. Following illumination, 
immediately, the optical density of all the reaction 
mixtures was read at 560 nm units for enzyme 
present in the sample which was expressed as 





U/mg protein (saliva) and U μg/Hb (serum) (6,7). 
The serum and salivary samples were analysed 
using the Systronics spectrophotometer.  
 
Method of analysis 
 
The data obtained from the study were analyzed 
using SPSS version 17.0 software. Independent t 
test was used to compare superoxide dismutase 
levels in the study and the control groups. 
Pearson’s correlation coefficient was used to 
correlate the changes in serum and saliva; P< 0.05 




Demographic data analysis of the groups 
Demographic data analysis of Control Group 
(Group I) 
 
The mean age in this group was 40.58 years. 
Females comprised of 48.9% (22/45) while males 
comprised of 51.1% (23/45) (Table 1, Figure 1). 
 
Demographic data analysis of Study Group 
(Group II) 
 
The mean age in this group was 47.91 years. 
Females comprised of 60.0% (27/45) while males 
comprised of 40.0% (18/45) (Table 1 Figure 1). In 
the study group, among 45 patients with Type 2 
diabetes Mellitus, 42 had Dental caries, 39 had 
Chronic periodontitis, 5 had Gingivitis, 2 had 
Candidiasis and 1 had Denture stomatitis. Most of 
the patients showed combinations of two oral 
manifestations. 
The mean Random Blood Sugar level of 
Control Group (Group I) was 102.71 mg/dl, and 
the mean Random Blood Sugar level of Study 
Group (Group II) was 210.91 mg/dl. In the study 
Group (Group II), 28/45 patients were poorly 
controlled diabetics, and 17/45 were well 
controlled diabetics. The mean duration of Type 2 
diabetes in Study group (Group II) was 8.73 years. 
 
 


















Table 1: Age and Gender Distribution in Healthy Subjects and Subjects With Type 2 Diabetes 
Mellitus 
 
GROUP N MEAN AGE STANDARD 
DEVIATION 




45 47.91 7.633 
GROUP 
 
MALE FEMALE TOTAL 




18 27 45 
TOTAL 41 49 90 
 
Analysis of mean serum and salivary 
Superoxide dismutase levels in Controls and 
Type 2 Diabetics with oral manifestations 
 
Mean Serum Superoxide dismutase levels 
 
The mean serum Superoxide dismutase level in 
Group I was 4.315 U/mg of Hb. The mean serum 
Superoxide dismutase level of Group II was 2.833 
U/mg of Hb (Table 2 Figure 2). 
 
Mean Salivary Superoxide dismutase levels 
 
The mean salivary Superoxide dismutase level in 
Group I was 0.169 U/mg of Protein. The mean 
salivary Superoxide dismutase levels of Group II 
was 0.104 U/mg of Protein (Table 2 Figure 2).  
 
 
Figure 2: Mean Serum and Salivary 
Superoxide Dismutase Levels 
Analysis of Statistical Significance 
 
Serum and Saliva Superoxide dismutase levels 
 
When serum levels of Superoxide dismutase were 
compared between Group I (4.315 U/mg of Hb) 
and Group II (2.833 U/mg of Hb), highly 
significant differences were obtained (p<0.001) 
(Table 2). On comparing salivary Superoxide 
dismutase levels of Group I (0.169 U/mg of 
Protein) and Group II (0.104 U/mg of Protein), the 
























































45 0.1042 0.0258    
 
 
Correlation of Serum Superoxide dismutase with Salivary Superoxide dismutase levels among the 
two groups 
 
GROUP I: Good positive correlation was observed between serum and salivary Superoxide dismutase 
levels (r = 0.412) (Table 3 Figure 3). 
GROUP 2: Very good positive correlation was observed between serum and salivary Superoxide dismutase 
levels (r = 0.767) (Table 3 Figure 3). 
 









Table 3: Correlation of Salivary and Serum Levels Using Pearsons Correlation 
 
 












  SIG. (2-TAILED) 
 
0.05 













  SIG. (2-TAILED) 
 
<0.001 
  N 
 
45 








The term diabetes mellitus is derived from the 
Greek word for “siphon” that means “passing 
through (urine)”, and the word mellitus is derived 
from Latin, which means “honey”. Diabetes 
mellitus means literally ‘honey sweet urine’ (8). 
The incidence of type 2 DM varies substantially 
from one geographical region to another as a result 
of environmental and lifestyle risk factors (2).  
The rise in the prevalence of Type 2 diabetes 
mellitus (DM) is viewed as an urban phenomenon 
with large Indian cities showing four-fold higher 
rates than rural populations. In contrast, the 
prevalence of impaired glucose tolerance (IGT) 
and impaired fasting glycaemia (IFG), considered 
pre-diabetic, appears to be common in both urban 
and rural communities. The majority of people 
with Type 2 DM in developing countries are aged 
45–64 years, in contrast to >65 years in developed 
countries. In a recent Indian survey, 56% of the 
individuals with Type 2 DM were diagnosed 
between 40 and 59 years of age and 25% between 
20 and 39 years (9). In our study, the mean age of 
the patients in the study group consisting of Type 
2 diabetics with oral manifestations was 47.91 
years.  
Abnormally high levels of lipid peroxidation 
and the simultaneous decline of antioxidant 
defense mechanisms can lead to damage of 
cellular organelles and lead to oxidative stress. 
The antioxidant status of patients may determine 
whether they develop microvascular or 
macrovascular complications. Many medical 
researchers have found that the depletion of body 
chemicals called antioxidants may increase the 
risk of complication from diabetes mellitus (10). 
An antioxidant can be defined as “any 
substance that when present in low concentration 
compared to that of an oxidizable substrate 
significantly delays or inhibits the oxidation of 
that substance”. Radicals have the capacity to 
react in an indiscriminate manner leading to 
damage in almost any cellular component. An 
extensive range of antioxidant defenses, both 
endogenous and exogenous, are present to protect 
cellular components from free radical induced 
damage (11). Superoxide dismutase (SOD) is 
widely distributed in oxygen-metabolizing cells 
and has been supposed to protect such cells 
against the deleterious action of superoxide radical 
(12). 
In this study, the mean serum Superoxide 
dismutase level in healthy controls was 4.315 
U/mg of Hb. However, in subjects with Type 2 
diabetes mellitus with oral manifestations, it was 
reduced to 2.833 U/mg of Hb which was 
significantly lower than the controls. This was in 
consistent with the studies conducted by 
Sundaram RK et al
 
(13) and Rahbani-Nobar ME et 
al
 
(14) where they stated that in diabetic patients, 
the autoxidation of glucose results in the 
formation of hydrogen peroxide which inactivates 
SOD. Therefore, the accumulation of hydrogen 
peroxide may be one of the explanations for 
decreased activity of SOD in these patients. The 
primary catalytic cellular defense that protects 
cells and tissues against potentially destructive 
reactions of superoxide radicals and their 
derivatives is the Cu/Zn-SOD. It has been 
observed that SOD can be rapidly induced in some 
conditions when cells or organisms are exposed to 
oxidative stress. The low activity of SOD in 
diabetes mellitus may suggest that with longer 
disease duration, SOD induction and consequently 
its activity progressively decreases. In addition the 
nonenzymatic glycation which is the other cause 
for hydrogen peroxide production leads to further 
inhibition of Cu/Zn SOD. 
Further, this study is consistent with studies 
conducted by Taheri E et al
 
(16) and Sayed et al
 
(17) in which the decrease of SOD activity was 
noticed. This could be attributed to the following 
reasons: 
1. Hyperglycemia activates various biochemical 
pathways such as glucose autoxidation, 
nonenzymatic glycation of proteins and activation 
of protein kinase C. This, in turn, overproduces 
oxidants like superoxide, hydroxyl radicals and 
hydrogen peroxide.  
2. The increase of glycosylated SOD that leads to 
the inactivation of this enzyme. (3) Loss of its two 
factors, Zn2+ and Cu2+. 
Todate, salivary studies which have been 
documented in literature are very few. This study 
showed a significant reduction in SOD in Type 2 
Diabetics with oral manifestations when compared 
to controls. The results are in accordance with the 
study conducted by Trivedi S et al
 
(4). This study 
stated that the decreased SOD in the saliva of 




Diabetics might be a consequence of antioxidant 
depletion. The depletion of the antioxidant is 
attributable to ongoing free radical activity and 
breakdown of protective antioxidant species. The 
reduction in the activitis of SOD may be 
attributable to excessive oxygen radical 
production from autooxidation of glucose, 
glycated proteins and glycation of antioxidative 
enzymes, which limit their capacity to detoxify 
oxygen radicals. In the case of Diabetes Mellitus, 
there is ROS production, but the body is not 
adapted for the required antioxidant formation. 
Thus, the level of SOD decreases because of 
enzymatic use. 
In this study, the correlations of Serum 
Superoxide dismutase with Salivary Superoxide 
dismutase in the two groups were analyzed. The 
Pearsons correlation analysis revealed good 
positive correlation between serum and salivary 
Superoxide dismutase in healthy subjects (r = 
0.412), and very good positive correlation was 
observed between serum and salivary Superoxide 
dismutase in subjects with Type 2 Diabetes 
Mellitus with oral manifestations (r = 0.767). 
Thus, antioxidant parameter assessed in saliva of 
diabetic patients may be of great importance in 
evaluating the activity and severity of the disease. 
The findings of this study suggest the potential 
role of saliva as an adjunctive tool to monitor 
prognosis of diabetes mellitus. This study 
highlights that Type 2 diabetic patients undergo 
decline of antioxidant defence systems that leads 
to the development of complications. 
In conclusion, saliva could be used as a 
reliable, non-invasive tool in the assessment of 
antioxidant levels which may give a substantial 
insight into the pathogenesis and evolution of 
diabetes mellitus. Saliva may be a valuable tool in 
evaluating the progression and severity of diabetes 
mellitus.   
Further extensive studies are required to be 
conducted with larger samples along with 
antioxidant therapy. This will help in establishing 
the reliability of Superoxide dismutase in saliva as 
a potential biomarker of oxidative stress in 
diabetes mellitus. Further, it may also help in 
establishing the role of oxidative stress in the 
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